Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Metabolism Drugs Market to reach USD 26.64 billion by the end of 2030.

Global Metabolism Drugs Market Size study & Forecast, by Drug Type (Antidiabetic Drugs, Lipid Lowering Drugs, Anti-Obesity Drugs, Thyroid Hormone Drugs, Others) by Indication (Diabetes, Hyperlipidaemia, Obesity, Hypothyroidism) and Regional Analysis, 2023-2030

Product Code: HLSDT-65923287
Publish Date: 20-07-2023
Page: 200

Global Metabolism Drugs Market is valued approximately at USD 16.10 billion in 2022 and is anticipated to grow with a growth rate of more than 6.50% over the forecast period 2023-2030. A metabolism drug refers to a medication or treatment that specifically targets and affects the body’s metabolic processes. Metabolism encompasses the chemical reactions and processes that occur within cells to convert food and nutrients into energy, as well as the breakdown and elimination of waste products. A metabolism drug is designed to either stimulate or inhibit certain metabolic pathways in order to achieve desired therapeutic outcomes. These drugs can be used to regulate or enhance metabolism, manage conditions related to metabolic disorders, promote weight loss, or address specific metabolic dysfunctions. Metabolism drugs are developed through rigorous research and testing to ensure safety and efficacy in modulating the body’s metabolic functions. Moreover, increasing prevalence of chronic disease and rising geriatric population are anticipated market drivers. Furthermore, growing pharmaceuticals industry and increasing medical tourism for advanced healthcare treatment fuel the market space during the forecast period 2023-2030.

The prevalence of noncommunicable diseases (NCDs) affecting diverse populations presents a significant growth opportunity for the metabolism drug market. According to the World Health Organization (WHO) in 2022, NCDs impact individuals of various age groups, regions, and nations, with 17 million premature NCD-related deaths occurring before the age of 70. Particularly concerning is that 86% of these premature deaths transpire in low and middle-income countries. Risk factors such as unhealthy diets, physical inactivity, tobacco exposure, and excessive alcohol consumption make people across different age groups susceptible to these conditions. Metabolism drugs play a crucial role in addressing these risk factors and can contribute to the prevention, management, and treatment of NCDs, benefiting individuals globally. According to the World Health Organization (WHO) in 2020, the population of individuals aged 60 years and above increased from 1 billion to 1.4 billion, with expectations of reaching a staggering 2.1 billion globally. Additionally, there is an anticipation of the number of individuals aged 60 years or older tripling between 2020 and 2050, accounting for approximately 426 million individuals. However, side effects & safety concerns and high cost of development may hamper market growth.
The key regions considered for the Global Metabolism Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the dominant region in the Metabolism Drug Market with largest market share. Firstly, the region boasts a robust pharmaceutical industry with advanced research and development capabilities, leading to the production of innovative metabolism drugs. Secondly, North America has a significant population affected by metabolic disorders, creating a substantial market demand for effective treatments. Additionally, the region benefits from well-established healthcare infrastructure, including advanced medical facilities and favorable reimbursement policies, ensuring widespread access to metabolism drugs. Lastly, the presence of key market players and research institutions focused on metabolic disorders further solidifies North America’s position as a leader in the metabolism drug market. Asia Pacific is expected to be the fastest growing market for metabolism drugs due to factors such as a large and expanding population, improving healthcare infrastructure, rising disposable incomes, growing awareness of metabolic health, and government initiatives promoting healthcare advancement.

Major market player included in this report are:
Merck Sharp & Dohme LLC
Novartis AG
Amicus Therapeutics Inc.
AstraZeneca PLC.
Boehringer Ingelheim International GmbH
Takeda Pharmaceutical Company Limited
Sanofi S.A.
GlaxoSmithKline PLC.
Horizon Therapeutics PLC
BioMarin Pharmaceutical Inc.

Recent Developments in the Market:
Ø In January 2023, Researchers from the University of Galway, affiliated with APC Microbiome Ireland, have created a new resource of digital microbes specifically focused on drug metabolism. This collection of over 7,000 digital microorganisms allows for computer simulations and predictions of metabolic changes in individuals, offering insights into how pharmacological treatments may function and how patients might respond. The tool holds significant potential for studying diseases such as inflammatory bowel, Parkinson’s, and colorectal cancer, marking a significant milestone in understanding the human response to medical therapy.
Ø In March 2023, A team of researchers from the Indian Institute of Science Education and Research in Bhopal has developed an artificial intelligence (AI) system that can predict how the gut flora would metabolize various foods and medications. This web-based application focuses on the specific bacterial enzymes, processes, and bacteria involved in the digestion and absorption of food in the human gut. The system holds promise in understanding the complex interactions between gut flora and metabolism.

Global Metabolism Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drug Type, Indication, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:
Antidiabetic Drugs
Lipid Lowering Drugs
Anti-Obesity Drugs
Thyroid Hormone Drugs

By Indication:

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Metabolism Drug Market, by region, 2020-2030 (USD Billion)
1.2.2. Metabolism Drug Market, by Drug Type, 2020-2030 (USD Billion)
1.2.3. Metabolism Drug Market, by Indication, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Metabolism Drug Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Metabolism Drug Market Dynamics
3.1. Metabolism Drug Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Growing prevalence of Chronic Disease Rising geriatric population
3.1.2. Market Challenges High cost of metabolism drug
3.1.3. Market Opportunities Growing pharmaceuticals industry Increasing medical tourism
Chapter 4. Global Metabolism Drug Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Metabolism Drug Market, by Drug Type
5.1. Market Snapshot
5.2. Global Metabolism Drug Market by Drug Type, Performance – Potential Analysis
5.3. Global Metabolism Drug Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
5.4. Metabolism Drug Market, Sub Segment Analysis
5.4.1. Antidiabetic Drugs
5.4.2. Lipid Lowering Drugs
5.4.3. Anti-Obesity Drugs
5.4.4. Thyroid Hormone Drugs
5.4.5. Others
Chapter 6. Global Metabolism Drug Market, by Indication
6.1. Market Snapshot
6.2. Global Metabolism Drug Market by Indication, Performance – Potential Analysis
6.3. Global Metabolism Drug Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
6.4. Metabolism Drug Market, Sub Segment Analysis
6.4.1. Diabetes
6.4.2. Hyperlipidaemia
6.4.3. Obesity
6.4.4. Hypothyroidism
Chapter 7. Global Metabolism Drug Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Metabolism Drug Market, Regional Market Snapshot
7.4. North America Metabolism Drug Market
7.4.1. U.S. Metabolism Drug Market Drug Type breakdown estimates & forecasts, 2020-2030 Indication breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Metabolism Drug Market
7.5. Europe Metabolism Drug Market Snapshot
7.5.1. U.K. Metabolism Drug Market
7.5.2. Germany Metabolism Drug Market
7.5.3. France Metabolism Drug Market
7.5.4. Spain Metabolism Drug Market
7.5.5. Italy Metabolism Drug Market
7.5.6. Rest of Europe Metabolism Drug Market
7.6. Asia-Pacific Metabolism Drug Market Snapshot
7.6.1. China Metabolism Drug Market
7.6.2. India Metabolism Drug Market
7.6.3. Japan Metabolism Drug Market
7.6.4. Australia Metabolism Drug Market
7.6.5. South Korea Metabolism Drug Market
7.6.6. Rest of Asia Pacific Metabolism Drug Market
7.7. Latin America Metabolism Drug Market Snapshot
7.7.1. Brazil Metabolism Drug Market
7.7.2. Mexico Metabolism Drug Market
7.8. Middle East & Africa Metabolism Drug Market
7.8.1. Saudi Arabia Metabolism Drug Market
7.8.2. South Africa Metabolism Drug Market
7.8.3. Rest of Middle East & Africa Metabolism Drug Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Merck Sharp & Dohme LLC Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Novartis AG
8.3.3. Amicus Therapeutics Inc.
8.3.4. AstraZeneca PLC.
8.3.5. Boehringer Ingelheim International GmbH
8.3.6. Takeda Pharmaceutical Company Limited
8.3.7. Sanofi S.A.
8.3.8. GlaxoSmithKline PLC.
8.3.9. Horizon Therapeutics PLC
8.3.10. BioMarin Pharmaceutical Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now